Decision making on medicines informed by quantitative benefit-risk assessment may differ depending on the perspective of the decision maker and the phase of drug development. This module will address the decision-making on medicines by different stakeholders and how to apply advanced benefit-risk assessment tools in this process. Topics covered include: Multi-criteria decision analysis Conjoint analysis Personalized benefit-risk assessment